Prior human endemic coronavirus exposure does not affect humoral responses to SARS-CoV-2 protein vaccines
Abstract We included measurement of pre-existing immunity to human endemic coronaviruses (HCoV) in a Phase I/II study of SARS-CoV-2 spike protein vaccine candidates. A Binding Antibody Multiplex Assay measured HCoV-specific IgG to the receptor binding domain or full-length spike of human coronavirus...
Saved in:
| Main Authors: | Guy de Bruyn, Haritha Adhikarla, Caroline K. Brackett, Yichen Jia, Premkumar Lakshmanane, Sarah V. Mudrak, Sheetal Sawant, Donghui Zhang, Roman M. Chicz, Saranya Sridhar, Georgia D. Tomaras, Kelly E. Seaton |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-025-01203-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shigella humoral immunity during the first 2 years of life in children from endemic areas
by: Esther Ndungo, et al.
Published: (2025-05-01) -
Abstract 069: Alteplase Or Tenecteplase Prior To Endovascular Therapy – Does It Matter?
by: Sheetal Hegde, et al.
Published: (2023-11-01) -
Association between prior tuberculosis disease and dysglycemia within an HIV-endemic, rural South African population.
by: Alison C Castle, et al.
Published: (2023-01-01) -
GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies.
by: Lin Lin, et al.
Published: (2024-11-01) -
Humorous factors and main types of humor
by: Ghahreman Shiri
Published: (2024-07-01)